Financial Instruments and Derivative Instruments (Details 2) In Millions, unless otherwise specified	3 Months Ended		12 Months Ended			3 Months Ended
	Mar. 30, 2014 Tekmar USD ($)	Jun. 30, 2013 Tekmar USD ($)	Dec. 31, 2013 Tekmar USD ($)	Jan. 30, 2012 Tekmar USD ($)	Jan. 30, 2012 Tekmar CAD	Mar. 30, 2014 Contingent consideration USD ($)
Reconciliation of changes in fair value of all financial assets and liabilities
Balance at the beginning of the period						$ 4.4
Purchases, sales, settlements, net						(2.2)
Total realized and unrealized (gains) losses included in Comprehensive income						(0.1)
Balance at the ending of the period						2.1
Initial purchase price paid					18.0
Contingent liability of the acquisition date fair value				5.1
Contingent liability				0
Contingent liability in case of complete achievement of performance metrics				8.2
Increase in fair value of contingent liability based on a revised estimate of the fair value of the contingent consideration			1.0
Portion of contingent consideration paid on achievement of performance metrics	$ 2.2	$ 1.2